Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

The spanlastic system effectively delivers green tea extract for skincare.

Teledermatology is crucial and effective for remote skin care in India.

Extracellular vesicles are important for disease treatment and monitoring.

Chinese black tea extract helped mice grow hair, especially when combined with capsaicin.

The protein ER71/ETV2 helps regrow hair after chemotherapy by improving the growth of new blood vessels.

A gene called Taqpep affects cat coat patterns like stripes and blotches.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Direct-to-consumer telemedicine in Australia needs formal evaluation for safety and quality.

A standardized guideline would improve Telogen Effluvium management.

Small extracellular vesicles from stem and immune cells show promise for treating various diseases but face challenges in clinical use.

TAF4 is important for skin cell growth and helps prevent skin cancer in mice.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

EV-based drug delivery shows promise but faces challenges in standardization and scalability.

TTD patients don't have a higher skin cancer risk because their main issue is with transcription, not DNA repair.

People with Telogen Effluvium have lower vitamin D levels.

Combining online and in-person dermatology care can improve quality and access.

Alfredo Rebora suggests a simpler classification for hair loss and a new test for easier diagnosis.

AVT is highly conserved and may have antimicrobial properties.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Telogen effluvium negatively affects quality of life, increasing stress, depression, and anxiety.

Technology, like stem cell therapy and teledermatology, is improving dermatology care.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.